Experienced Trial Attorneys
Committed To Your Full Recovery
Dangerous Drugs And Pharmaceuticals
The Food and Drug Administration (FDA) requires pharmaceutical companies to conduct human trials to test the safety and efficacy of prescription drugs. Unfortunately, drug companies sometimes bring drugs to the market before all side effects are known — and fail to report those side effects once they become known. In some cases, doctors prescribing the drug are not aware of dangerous and potentially life-threatening drug reactions.
When prescription drugmakers sell medications that are unreasonably dangerous or without adequate safety warnings, the civil trial lawyers of Ginsberg & O'Connor, P.C., are here to help. From our office in Mount Laurel, we represent people throughout New Jersey who were harmed by prescription drugs. We offer a free initial consultation to discuss your case.
Prescription Drug Lawsuits
Examples of prescription drugs that have caused patient injuries and death include:
- Avandia and Actos (type 2 diabetes drugs)
- GranuFlo and NaturaLyte (drugs used in dialysis)
- Paxil, Prozac and Zoloft (antidepressants)
- Yaz and Yasmin (birth control pills)
- Ortho Evra (birth control patch)
- Accutane (medication for acne)
- Pradaxa and Xarelto (blood thinners)
- Fosamax (osteoporosis treatment)
- Baycol and Lipitor (heart conditions)
- Bextra and Rituxan (pain relievers)
Under New Jersey law, if you are injured by a prescription drug that does not contain adequate safety warnings or is unreasonably dangerous, you have a right to recover damages for medical bills, lost wages, pain and suffering, and other losses.
Contact Our Prescription Drug Error Attorneys
For more information about your options if you or a loved one was harmed by a dangerous drug or pharmaceutical, contact the medical malpractice attorneys at Ginsberg & O'Connor, P.C., in Mount Laurel for a confidential consultation. Call us at 856-437-0969, toll free 800-598-3944 or complete our simple contact form to schedule a free initial consultation.